VIRMA and testicular germ cell tumor: In our cohort of 122 TGCT patients, VIRMA (and the m6A reader YTHDF3) was found to be significantly upregulated (at both transcript and protein levels) in SE compared to NS subtypes, confirming in silico data reporting these two m6A-related players as the most upregulated in TGCTs.